Advertisement

Physician's First Watch

Physician's First Watch

Medical news from NEJM Journal Watch

September 22, 2014

By the Editors

Some 160 people in 22 states have been confirmed to have had...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The benefits of blood pressure-lowering in patients with type 2 diabetes and mild hypertension or normotension persist for years after treatment has ended, according to post-trial follow-up from the ADVANCE study published in the New England Journal of Medicine.

In ADVANCE,...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH

The New York Times this weekend put the spotlight on so-called "drive-by doctoring" — in which assistants, consultants, and other providers are called in, often when their need is uncertain,...

Comments (0)

By Larry Husten

Edited by André Sofair, MD, MPH

The FDA has approved dulaglutide — a once-weekly, injectable, glucagon-like peptide-1 (GLP-1) receptor agonist — to control blood sugar in adults with type 2 diabetes. The drug will...

Comments (0)

September 19, 2014

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

An FDA advisory panel voted on Wednesday to limit...

Comments (3)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Influenza vaccination rates among healthcare workers and pregnant women could be better, according to three articles in MMWR.

In the first, CDC researchers surveyed some 1900 healthcare personnel from various...

Comments (0)

By the Editors

President Obama on Thursday issued an executive order to form a government task force and...

Comments (0)

Pages